Opposing roles for complement component C5a in tumor progression and the tumor microenvironment

Area of Science:

• Immunology
• Oncology
• Complement system

Background:

• Complement activation can aid anti-tumor antibody efficacy but C5a can promote tumor growth.
• The dual role of C5a in tumor progression requires further investigation.

Purpose of the Study:

• To investigate the concentration-dependent role of C5a in tumor growth and the tumor microenvironment.
• To determine how C5a influences immune cell infiltration and cytokine production in different tumor models.

Main Methods:

• Transfection of human carcinoma and murine lymphoma cells with mouse C5a.
• In vitro growth assays and in vivo studies using tumor-bearing mice.
• Analysis of immune cell infiltration (NK cells, macrophages, myeloid cells, T cells) and cytokine levels (VEGF, arginase, TNF-α, IFN-γ).

Main Results:

• C5a expression did not affect in vitro tumor cell growth.
• Xenografted tumors with C5a showed reduced burden, increased NK and macrophage infiltration, and decreased pro-tumorigenic factors.
• Syngeneic lymphoma with high C5a exhibited accelerated growth, increased myeloid cells, and decreased T cells; low C5a led to reduced tumor burden and increased T cell activity.

Conclusions:

• Tumor C5a concentration critically dictates its role in tumor progression.
• Local C5a levels modulate the tumor microenvironment, influencing immune cell infiltration and anti-tumor immunity.